Physician profile
Hai-Yan Li
NPI 1669688420
$1,210.54
in general payments reported to CMS, 2019-2025
14 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.19 · 2021: $145 · 2022: $68.00 · 2023: $78.27 · 2024: $418 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $297.30 | 2025 | Coolief Cooled Radiofrequency |
| Spr Therapeutics, INC | $163.73 | 2022-2024 | Sprint Pns System |
| Zimmer Biomet Holdings, INC. | $147.13 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Sk Life Science, INC. | $145.33 | 2021 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Corcept Therapeutics | $103.80 | 2025 | Korlym |
| Emd Serono, INC. | $41.25 | 2023 | Mavenclad |
| Scilex Pharmaceuticals INC. | $37.02 | 2023 | Ztlido |
| Pacira Therapeutics, INC. | $36.07 | 2019 | |
| Averitas Pharma INC. | $35.09 | 2024-2025 | Qutenza |
| Nalu Medical, INC. | $34.70 | 2024 | Nalu Neurostimulation System |
| Sanofi-Aventis U.S. LLC | $17.51 | 2019 | |
| Assertio Therapeutics, INC. | $14.77 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hai-Yan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.